Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease
Health65%★
- title/description contains "disease"
Importance Score
Low importanceWhy this vote stands out:
- ✓Some political group division
- ✓High participation
- ✓Many MEPs voted against their group
Show full breakdown
Methodology: importance-v0.1 · The Importance Score is a prioritisation indicator. It does not judge whether a vote is good or bad.
What was this vote about?
This vote concerned “Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease”. EPP, S&D, Renew, Greens-EFA, PfE, ECR and NI voted mostly in favour, while Left and ESN voted mostly against. The motion was adopted by a comfortable margin (618 for, 62 against, 13 abstentions).
Automated summary generated from official vote metadata and observed voting patterns. Not a legal interpretation.
Why it matters
This is a substantive vote (such as an amendment or resolution) that contributes to shaping the final position of the Parliament on a dossier. It reflects the political direction taken on specific provisions.
Result analysis
By political group
Country angle
- Germany75
- France73
- Italy61
- Spain52
- Poland51
None.
None notably divided.
Full breakdown by all countries
Individual MEP positions
Loading individual positions…